Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

"The Chinese poultry lineage may have experienced more vaccine-driven selection compared to other lineages," the researchers ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The rapid creation of COVID-19 vaccinations saved millions of lives around the world, but it was followed by hundreds of ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

In an effort to combat the growing threat of monkeypox (mpox), scientists from Türkiye and the United Kingdom have joined ...

Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond ...

CLAIM: HIV is part of the composition of COVID-19 vaccinesFACT: False. An experimental vaccine developed by Professor Keith ...

The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.